Are Black Holes Really 2D Holograms and Other Future Tech

Today in Future Tech - Are Black Holes Really 2D Holograms and New Brain Cancer Treatment Leads to Cure in Trails.

Today, we’re going to start off with a question that has intrigued physicists across the world – where does stuff go when it enters a black hole?

Are Black Holes Really 2D Holograms

We all know that information that even light cannot escape a black hole. But, what does that mean for the law of conservation of energy. Actually, renowned theoretical physicist Prof Stephen Hawking proposed in 2015 that black holes might be 2D holograms of information.

“The information is not stored in the interior of the black hole as one might expect, but in its boundary – the event horizon. The idea is the super translations are a hologram of the ingoing particles”, said Prof Hawking. Thus they contain all the information that would otherwise be lost. This information is emitted in the quantum fluctuations that black holes produce, albeit in chaotic, useless form. For all practical purposes the information is lost.”

But wait! Alternate histories in black holes? “The existence of alternative histories with black holes suggests this might be possible. The hole would need to be large and if it was rotating it might have a passage to another Universe. But you couldn’t come back to our Universe. So although I’m keen on space flight, I’m not going to try that,” he added. Interesting theory, indeed!

New Brain Cancer Treatment Leads to Cure in Trails

One of the toughest nuts to crack is brain cancer, due to the fact that even a miniscule amount damage has the potential to end lives. But now, thanks to medical technology, researchers have engineered a new type of viral treatment that shows a survival time of 13.6 months for patients suffering from Glioblastomas. This is huge when compared to the survival time of patients who didn’t receive the treatment. Some patients lived upto more than 2 years without many side effects.

First, the patient is given an injection with Toca 511 - a virus that delivers an enzyme called cytosine deaminase (CD). This spreads throughout the tumor and that converts Toca FC (an oral antifungal drug) into 5-fluorouracil, an FDA-approved anticancer drug.

"For the first time, this clinical data shows that this treatment, used in combination with an antifungal drug, kills cancer cells and appears to activate the immune system against them while sparing healthy cells," said Dr. Timothy Cloughesy, Director of the Neuro-Oncology at the University of California, Los Angeles and Consultant for Tocagen – the biopharmaceutical that developed and funded most of the research.

Companies like Tocagen are pioneers of a movement to develop quality software applications for the healthcare industry. Q3 Technologies is a large diversified technology company offering technology consulting and software development outsourcing services to the global IT industry.

License: You have permission to republish this article in any format, even commercially, but you must keep all links intact. Attribution required.